Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of a Pandemic Influenza Vaccine in Elderly Participants

NCT00376402 is registered in ClinicalTrials.gov with Seqirus as lead sponsor.

NCT NCT00376402
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00376402 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of a Pandemic Influenza Vaccine in Elderly Participants
Lead sponsor
Seqirus
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2006
Completion date
June 30, 2007
Enrollment
200
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

influenza